LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Monday reported a loss of $27.4 million in its fourth quarter.

The Lexington, Massachusetts-based company said it had a loss of 46 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.

The gene therapy company posted revenue of $15.3 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $9.7 million.

For the year, the company reported a loss of $119.7 million, or $2.04 per share. Revenue was reported as $40.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR